April 14, 2023

Top international researcher as guest

Prof. Dr. Mike (Przemlysaw) Sapieha, an expert in translational eye research at the University of Montreal in Canada, visited the FOR2240 research group and the Chair of Experimental Immunology of the Eye at the Center for Ophthalmology of the University Hospital Cologne and the Faculty of Medicine at the end of March. For several years, there has been a close research collaboration on the role of the immune system in age-related macular degeneration (AMD), the most common cause of vision loss in older age.
January 7, 2023

Rare eye diseases: Eight million euros for research: Funding for four years

The European Union has supported a research proposal on new therapies to restore visual acuity in rare and severe ocular surface diseases under the Horizon Health program. The RESTORE VISION consortium, consisting of the Universities of Cologne, Galway, Milan, Linjöping and Paris, and four industrial partners, has received a total of eight million euros in funding over four years.
December 15, 2022

Experimental Glaucoma Research Group awarded and funded

The Experimental Glaucoma Research Group at the Department of Ophthalmology of the University Hospital of Cologne and the Faculty of Medicine, headed by Univ.- Prof. Dr. Verena Prokosch, has received funding and awards.
November 17, 2020

Antonia Howaldt accepted into the Cologne Clinician Scientist Program

We proudly announce that Antonia Howaldt has been accepted into the Clinician Scientist Program of the Medical Faculty of the University of Cologne. Designed for physician-scientists seeking careers that combine research with clinical training, the Cologne Clinician Scientist Program offers a three-year program with protected research time supporting translational research […]
May 13, 2020

Retreat 2020 in times of Corona

A few days before the FOR2240 wanted to have the retreat in a cozy cottage in Bedburg (https://danielshof.de/), the Corona wave started to hit Cologne. Consequently, every larger meeting had to be canceled and the FOR2240 held a small full-day meeting – only the principal investigators – in the Lecture […]
May 13, 2020

FOR 2240 Retreat 2019 Abbey Brauweiler

Thirdy-two members of the German Research Foundation (DFG) Research Unit FOR 2240 met on the 8th of March 2019 in the Abbey of Brauweiler. It was the first time the principal investigators of the FOR 2240 and associated scientists and clinicians met in this quiet and peaceful environment to present […]
March 19, 2020

Aniridie – new project against blindness

Aniridie is a rare but very serious inherent eye disease which is difficult to treat. The iris of the affected is incomplete or has not been formed at all during pregnancy, additionally, patients often suffer from a vascularized, dull cornea. It is not seldom that patient has a deformity of […]
October 22, 2019

Cologne eye researchers sweep up prizes in Berlin (again!)

An astounding number of awards for outstanding scientific achievements, eight in total, went to scientists and clinician-scientists of the Department of Ophthalmology at the University of Cologne and the DFG FOR2240 at the annual meeting of the German Ophthalmological Society (DOG) held in Berlin from September 26th to 29th 2019. […]
October 21, 2019

Double triumph for cologne scientist.

This year’s DOG Patent 2019 award went to Dr. Thomas Clahsen for his exceptional inventions in the area of ophthalmology. Dr. Clahsen is working at the University Hospital Cologne in the Department of Ophthalmology (Experimental Ophthalmology). This specific award is only given once a year and honors outstanding translational research […]